Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders
- PMID: 20694583
- DOI: 10.1007/s11920-010-0145-3
Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders
Abstract
Autism spectrum disorders (ASD) are frequently marked by symptoms consistent with attention-deficit/hyperactivity disorder (ADHD), namely inattention, hyperactivity, and impulsivity. Recent work has established that about half of the ASD population also meets diagnostic criteria for ADHD, although the comorbid diagnoses are precluded by the DSM-IV-TR. Individuals with co-occurring ASD and ADHD symptoms are more severely impaired, with significant deficits seen in social processing, adaptive functioning, and executive control. Children with ASD and ADHD symptoms are also prone to motor problems, which lead to especially poor outcomes. Recent work has also demonstrated high rates of ASD symptoms in a subset of children with ADHD. Medication studies have demonstrated the efficacy of methylphenidate, atomoxetine, and guanfacine, among others, in treating ADHD symptoms co-occurring with ASD. However, these effects were not as great as those seen when treating primary ADHD, and they are less well-tolerated in the ASD population.
Similar articles
-
Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.J Child Psychol Psychiatry. 2021 Jun;62(6):680-700. doi: 10.1111/jcpp.13305. Epub 2020 Aug 26. J Child Psychol Psychiatry. 2021. PMID: 32845025
-
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.J Child Adolesc Psychopharmacol. 2013 Sep;23(7):432-9. doi: 10.1089/cap.2012.0111. Epub 2013 Sep 9. J Child Adolesc Psychopharmacol. 2013. PMID: 24015896 Free PMC article.
-
[Autism and ADHD across the life span. Differential diagnoses or comorbidity?].Nervenarzt. 2011 May;82(5):573-80. doi: 10.1007/s00115-010-3239-6. Nervenarzt. 2011. PMID: 21484168 Review. German.
-
[Attention-deficit / hyperactivity disorder in autism spectrum disorders].Invest Clin. 2011 Jun;52(2):195-204. Invest Clin. 2011. PMID: 21866791 Review. Spanish.
-
Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.J Child Adolesc Psychopharmacol. 2013 Apr;23(3):194-9. doi: 10.1089/cap.2012.0012. Epub 2013 Apr 11. J Child Adolesc Psychopharmacol. 2013. PMID: 23578015 Clinical Trial.
Cited by
-
Association between SNAP-25 gene polymorphisms and cognition in autism: functional consequences and potential therapeutic strategies.Transl Psychiatry. 2015 Jan 27;5(1):e500. doi: 10.1038/tp.2014.136. Transl Psychiatry. 2015. PMID: 25629685 Free PMC article.
-
Defective response inhibition and collicular noradrenaline enrichment in mice with duplicated retinotopic map in the superior colliculus.Brain Struct Funct. 2015;220(3):1573-84. doi: 10.1007/s00429-014-0745-5. Epub 2014 Mar 20. Brain Struct Funct. 2015. PMID: 24647754 Free PMC article.
-
Evaluating the effect of R-Baclofen and LP-211 on autistic behavior of the BTBR and Fmr1-KO mouse models.Front Neurosci. 2023 Mar 30;17:1087788. doi: 10.3389/fnins.2023.1087788. eCollection 2023. Front Neurosci. 2023. PMID: 37065917 Free PMC article.
-
Rhythmic attentional sampling in autism.Autism Res. 2023 Nov;16(11):2090-2099. doi: 10.1002/aur.3021. Epub 2023 Sep 7. Autism Res. 2023. PMID: 37676241 Free PMC article.
-
Amygdalar neurotransmission alterations in the BTBR mice model of idiopathic autism.Transl Psychiatry. 2024 Apr 17;14(1):193. doi: 10.1038/s41398-024-02905-z. Transl Psychiatry. 2024. PMID: 38632257 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical